Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein

Oncogene

Volumn 24, Issue 18, 2005, Pages 2944-2953

  Fest, Thierry ^a,b   Guffei, Amanda ^a   Williams, Gaynor ^c   Silva, Santiago ^a   Mai, Sabine ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Lab Univ d'Hematologie Biol C   (France)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Burkitt's lymphoma; c Myc; Genome instability; SCID mice

Indexed keywords

MUTANT PROTEIN; MYC PROTEIN; MYC PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURKITT LYMPHOMA; CARCINOGENIC ACTIVITY; CELL IMMORTALIZATION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; GENOMIC INSTABILITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROTEIN EXPRESSION; SPECTRAL KARYOTYPING; WILD TYPE; ANIMAL; CHROMOSOME; DISEASE MODEL; GENE DELETION; GENETICS; METABOLISM; MOUSE MUTANT; MUTATION; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; BURKITT LYMPHOMA; CHROMOSOMES; DISEASE MODELS, ANIMAL; GENOMIC INSTABILITY; MICE; MICE, SCID; MUTATION; PROTO-ONCOGENE PROTEINS C-MYC; SEQUENCE DELETION;

EID: 18344387814     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208467     Document Type: Article

References (21)

1. Amin C, Wagner AJ and Hay N. (1993). Mol. Cell. Biol., 13, 383-390.
2. Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R and Magrath I. (1993). Nat. Genet., 5, 56-61.
3. Chang DW, Claassen GF, Hann SR and Cole MD. (2000). Mol. Cell. Biol., 20, 4309-4319.
4. Conzen SD, Gottlob K, Kandel ES, Khanduri P, Wagner AJ, O'Leary M and Hay N. (2000). Mol Cell. Biol., 20, 6008-6018.
5. Fest T, Mougey V, Daistein V, Hagerty M, Milette D, Silva S and Mai S. (2002). Oncogene, 21, 2981-2990.
6. Fukasawa K, Wiener F, Vande Woude GF and Mai S. (1997). Oncogene, 15, 1295-1302.
7. Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D, Larocca LM, Glghini A, Carbone A and Dalla-Favera R. (2003). Blood, 102, 1833-1841.
8. Goruppi S, Gustincich S, Brancolini C, Lee WM and Schneider C. (1994). Oncogene, 9, 1537-1544.
9. Klein G. (1986). AIDS Res., 2 (Suppl 1), S167-S176.
10. Kumagai H, Mukaisho K, Sugihara H, Bamba M, Miyashita T, Miwa K and Hattori T. (2003). Scand. J. Gastroenterol., 38, 687-692.
11. Kuttler F, Ame P, Clark H, Haughey C, Mougin C, Cahn JY, Dang CV, Raffeld M and Fest T. (2001). Oncogene, 20, 6084-6094.
12. Lee TC, Li L, Philipson L and Ziff EB. (1997). Proc. Natl. Acad. Sci. USA, 94, 12886-12891.
13. Li LH, Nerlov C, Prendergast G, MacGregor D and Ziff EB. (1994). EMBO J., 13, 4070-4079.
14. Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI. (1995). Nucleic Acids Res., 23, 1686-1690.
15. Mai S and Mushinski JF. (2003). J. Environ. Pathol. Toxicol. Oncol., 22, 179-199.
16. Marhin WW, Chen S, Facchini LM, Fornace Jr AJ and Penn LZ. (1997). Oncogene, 14, 2825-2834.
17. Nesbit CE, Tersak JM and Prochownik EV. (1999). Oncogene, 18, 3004-3016.
18. Oster SK, Mao DY, Kennedy J and Penn LZ. (2003). Oncogene, 22, 1998-2010.
19. Pasqualucci L, Meumeister P, Goossens T, Nanjangud G, Chaganti RSK, Küppers R and Dalla-Favera R. (2001). Nature, 412, 341-346.
20. Raffeld M, Yano T, Hoan AT, Lewis B, Clark HM, Otsuki T and Dang CV. (1995). Curr. Top. Microbiol. Immunol., 194, 265-272.
21. Stone J, De Lange T, Ramsay G, Jakobovits E, Bishop JM, Varmus H and Lee W. (1987). Mol. Cell. Biol., 7, 1697-1709.